SCHEDULE 13G DATED MARCH 8, 2017

Company

NovoCure Ltd

Filed

March 23, 2017

Accession Number

0001072613-17-000204

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →